Currently out of the existing stock ratings of Brooks O'neil, 75 are a BUY (93.75%), 5 are a HOLD (6.25%).

Brooks O'neil

Work Performance Price Targets & Ratings Chart

Analyst Brooks O'neil works at LAKE STREET with a stock forecast success ratio of 45.77% fulfilled within 224.05 days on average.

Brooks O'neil’s has documented 179 price targets and ratings displayed on 21 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on LMAT, LeMaitre Vascular at 02-Aug-2023.

Wall Street Analyst Brooks O'neil

Analyst best performing recommendations are on SMLR (SEMLER SCIENTIFIC).
The best stock recommendation documented was for SMLR (SEMLER SCIENTIFIC) at 7/30/2018. The price target of $22 was fulfilled within 3 days with a profit of $4.5 (25.71%) receiving and performance score of 85.71.

Average potential price target upside

ATEC Alphatec Holdings CSII Cardiovascular Systems JYNT The Joint Corp KIN Kindred Biosciences LMAT LeMaitre Vascular OPCH Option Care Health SMLR Semler Scientific SRDX SurModics SRGA Surgalign Holdings TNDM Tandem Diabetes Care AMEH Apollo Medical Holdings ARAY Accuray orporated DPLO Diplomat Pharmacy DYNT Dynatronics ELMD Electromed HROW Harrow Health INFU InfuSystems Holdings SIEN Sientra RCEL Avita Medical Ltd ICAD icad inc AUGX Augmedix

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

18

$2.66 (17.34%)

16

2 months 9 days ago

6/10 (60%)

$3.54 (24.48%)

253

Buy

24

$8.66 (56.45%)

25

3 months 21 days ago

3/5 (60%)

$13.15 (121.20%)

128

Buy

22

$6.66 (43.42%)

22

4 months 8 days ago

0/3 (0%)

$9.75 (79.59%)

Buy

22

$6.66 (43.42%)

17

6 months 24 days ago

3/4 (75%)

$6.07 (38.10%)

63

Buy

20

$4.66 (30.38%)

20

6 months 24 days ago

0/3 (0%)

$4.07 (25.55%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Brooks O'neil?

On 2017

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?